- Report
- March 2025
- 150 Pages
Global
From €4531EUR$4,850USD£3,833GBP
Gonadotrophin is a class of hormones that are involved in the regulation of reproductive processes in both males and females. They are used to treat endocrine and metabolic disorders, such as hypogonadism, infertility, and delayed puberty. Gonadotrophins are also used to induce ovulation in women with infertility.
Gonadotrophin drugs are typically administered via injection, and are available in both natural and recombinant forms. Natural gonadotrophins are derived from the urine of post-menopausal women, while recombinant gonadotrophins are produced through genetic engineering.
The gonadotrophin market is highly competitive, with a number of companies offering products for the treatment of endocrine and metabolic disorders. Some of the major players in the market include Merck, Ferring Pharmaceuticals, Teva Pharmaceuticals, and Pfizer. Show Less Read more